ClinConnect ClinConnect Logo
Search / Trial NCT06821776

Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study

Launched by LE BONHEUR CHILDREN'S HOSPITAL · Feb 6, 2025

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Bpd

ClinConnect Summary

This clinical trial is studying two different ways of feeding infants who have a serious lung condition called bronchopulmonary dysplasia (BPD) and are having trouble feeding. The researchers want to find out whether feeding directly into the stomach (gastric feeding) or feeding through a special tube that goes past the stomach into the small intestine (transpyloric feeding) works better for these infants. During the study, infants will receive one type of feeding for two weeks, then switch to the other type for another four weeks. Their breathing and overall health will be closely monitored to see which feeding method is best for each baby.

To be a part of this trial, infants must be born before 32 weeks of pregnancy and currently be in the neonatal intensive care unit (NICU) at Le Bonheur. They should also have moderate or severe BPD and show signs of feeding problems. However, infants with certain gastrointestinal issues or those expected to have surgery soon will not be eligible. Parents can expect their child to be carefully looked after during the study, with regular checks on their breathing and feeding tolerance. This trial is currently recruiting participants, and it's an important step towards improving care for infants with these challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients born \<32 weeks' gestation
  • Currently admitted to the Le Bonheur NICU
  • Grad 2 or 3 BPD (positive pressure or intubated at 36 weeks PMA)
  • Signs of gastroesophageal reflux, chronic aspiration, or other feeding intolerance.
  • Exclusion Criteria:
  • Known gastrointestinal anomalies
  • Unable to tolerate ≥100mL/kg/day enteral feeding
  • Congenital anomalies likely to alter feeding techniques
  • Surgical feeding tube in place or expected within the next 8 weeks
  • Expected to remain hospitalized \<8 weeks

About Le Bonheur Children's Hospital

Le Bonheur Children's Hospital is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research and compassionate care. With a commitment to excellence, the hospital conducts a wide range of clinical trials aimed at improving treatment options and outcomes for children with various medical conditions. Leveraging a multidisciplinary team of experts and state-of-the-art facilities, Le Bonheur strives to enhance the understanding of pediatric diseases while ensuring the safety and well-being of its young patients. Through its robust research initiatives, Le Bonheur Children's Hospital plays a vital role in shaping the future of pediatric medicine.

Locations

Memphis, Tennessee, United States

Patients applied

0 patients applied

Trial Officials

Mark Weems, MD

Principal Investigator

University of Tennessee

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported